SNP | Genotype | Â | Entire DPS | Â | Intervention group | Â | Control group |
---|---|---|---|---|---|---|---|
 |  | N | HR (95% CI), pa/q | N | HR (95% CI), pb/q | N | HR (95% CI), pb/q |
rs266729 | CC | 219 | 1 | 117 | 1 | 102 | 1 |
 | CG | 240 | 0.695 (0.513-0.942), 0.019/0.203 | 121 | 0.733 (0.453-1.185), 0.205/0.616 | 119 | 0.661 (0. 444-0.985), 0.042/0.237 |
 | GG | 48 | 0.615 (0.350-1.081), 0.091/0.330 | 21 | 0.400 (0.123-1.300), 0.128/0.616 | 27 | 0.743 (0.388-1.422), 0.370/0.818 |
 | CC | 219 | 1 | 117 | 1 | 102 | 1 |
 | CG, GG | 288 | 0.682 (0.510-0.912), 0.010/0.203 | 142 | 0.683 (0.428-1.090), 0.110/0.616 | 146 | 0.676 (0.464-0.985), 0.041/0.237 |
rs2241766 | TT | 460 | 1 | 231 | 1 | 229 | 1 |
 | TG | 45 | 1.521 (0.944-2.452), 0.085/0.330 | 28 | 1.320 (0.625-2.786), 0.466/0.616 | 17 | 1.648 (0.881-3.083), 0.118/0.470 |
 | GG | 2 | 5.448 (1.329-22.333), 0.019/0.203 | 0 | - | 2 | 4.993 (1.211-20.598), 0.026/0.237 |
 | TT | 460 | 1 | 231 | 1 | 229 | 1 |
 | TG, GG | 47 | 1.634 (1.035-2.579), 0.035/0.216 | 28 | 1.320 (0.625-2.786), 0.466/0.616 | 19 | 1.839 (1.028-3.289), 0.040/0.237 |
rs2082940 | CC | 466 | 1 | 233 | 1 | 233 | 1 |
 | CT | 39 | 1.383 (0.812-2.357), 0.233/0.668 | 26 | 1.356 (0.642-2.862), 0.425/0.616 | 13 | 1.352 (0.627-1.917), 0.442/0.821 |
 | TT | 2 | 5.368 (1.310-21.997), 0.020/0.203 | 0 | - | 2 | 4.885 (1.185-20.138), 0.028/0.237 |
 | CC | 466 | 1 | 233 | 1 | 233 | 1 |
 | CT, TT | 41 | 1.518 (0.918-2.512), 0.104/0.334 | 26 | 1.356 (0.642-2.862), 0.425/0.616 | 15 | 1.611 (0.813-3.196), 0.172/0.544 |